Effective Local Control and Long-Term Survival in Patients with T4 Locally Advanced Breast Cancer Treated with Breast Conservation Therapy

[1]  J. Pater.  Treatment of locally advanced breast cancer , 2004, Canadian Medical Association Journal.

[2]  S. Edge,et al.  Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. , 2003, The Surgical clinics of North America.

[3]  A. Hutcheon,et al.  Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. , 2003, American journal of surgery.

[4]  L. Carey,et al.  Long-Term Outcome of Neoadjuvant Therapy for Locally Advanced Breast Carcinoma: Effective Clinical Downstaging Allows Breast Preservation and Predicts Outstanding Local Control and Survival , 2002, Annals of surgery.

[5]  S. Jaffer,et al.  Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer * , 2002, Journal of surgical oncology.

[6]  T. Nose,et al.  Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer , 2002, Breast cancer.

[7]  L. Pusztai,et al.  Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. , 2001, American journal of surgery.

[8]  S. Singletary.  Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer. , 2001, American journal of surgery.

[9]  S. Jeffrey,et al.  Locally Advanced Breast Cancer: Is Surgery Necessary? , 2001, The breast journal.

[10]  S. Singletary,et al.  Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. , 2000, Journal of the American College of Surgeons.

[11]  G. Hortobagyi,et al.  Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  K. Hunt,et al.  Breast Conservation after Tumor Downstaging with Induction Chemotherapy , 1999 .

[13]  G. MacGrogan,et al.  Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS). , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  G. Hortobagyi,et al.  Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. , 1998, American journal of surgery.

[15]  T. Powles,et al.  A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  J. Rosenman,et al.  Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer. , 1998, International journal of radiation oncology, biology, physics.

[17]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  B. Leone,et al.  Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. , 1998, The cancer journal from Scientific American.

[19]  G. Bonadonna,et al.  Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  S. Merajver,et al.  Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  E. Touboul,et al.  Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  S. Singletary,et al.  Locally advanced noninflammatory breast cancer. , 1996, The Surgical clinics of North America.

[23]  A. Luini,et al.  Conservation Surgery After Primary Chemotherapy in Large Carcinomas of the Breast , 1993, Annals of surgery.

[24]  G. Calais,et al.  Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm , 1994, Cancer.

[25]  G. Hortobagyi.  Multidisciplinary management of advanced primary and metastatic breast cancer , 1994, Cancer.

[26]  B. Asselain,et al.  Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. , 1994, European journal of cancer.

[27]  G. Hortobagyi,et al.  Feasibility of breast‐conservation surgery after induction chemotherapy for locally advanced breast carcinoma , 1992, Cancer.

[28]  B. Asselain,et al.  Neoadjuvant chemotherapy in operable breast cancer. , 1991, European journal of cancer.

[29]  C. Jacquillat,et al.  Results of neoadjuvant chemotherapy and radiation therapy in the breast‐conserving treatment of 250 patients with all stages of infiltrative breast cancer , 1990, Cancer.

[30]  G. Hortobagyi,et al.  Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy , 1988, Cancer.

[31]  G. Hortobagyi,et al.  Multimodal treatment of locoregionally advanced breast cancer , 1983, Cancer.